Zoetis | ZTS - Sales Revenues

Stock Price
126.73
Daily Change
0.03 0.02%
Monthly
-2.03%
Yearly
-27.22%
Q1 Forecast
120.98

Zoetis reported $2.4B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Dentsply International USD 904M 32M Sep/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Henry Schein USD 3.34B 100M Sep/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.6B 610M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
Merck USD 16.4B 880M Dec/2025
Neogen USD 224.69M 15.5M Sep/2025
Pacira USD 179.52M 1.58M Sep/2025
Perrigo USD 1.04B 16.3M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Sanofi EUR 12.2B 3.19B Dec/2025
Zoetis USD 2.4B 60M Sep/2025